Company Spotlight

Aphena Pharma Solutions, Inc.

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile

Alcami

4620 Creekstone Drive
Durham, NC 27703
United States
View Profile


Contract Service Directory


Pfizer CentreOne





Company Headquarters

Corporate Headquarters:
235 E. 42nd Street
New York, NY 10017
United States

Company Description

Pfizer CentreOne® is a global CDMO embedded within Pfizer and a leading supplier of specialty APIs. Our global manufacturing network includes more than 35 sites across six continents. Backed by Pfizer resources, we deliver technical expertise, global regulatory support and long-term supply. For more than 40 years, we've been guiding complex compounds securely and efficiently from development through commercial manufacture. Working together with our customers, we combine our knowledge with open dialogue to solve challenges.Intellige nt collaboration with Pfizer CentreOne. For more information, visit w ww.pfizercentreone.c om.

Contract Service Directory

    Content From Pfizer CentreOne

    Related Content

    • Drug Development | R&D
      Top Pharma M&A Deals of 2019

      Top Pharma M&A Deals of 2019

      Drug manufacturers spent a record $342 billion on Mergers & Acquisitions
      Kristin Brooks, Contract Pharma 12.23.19

    • Breaking News | CRO News | Facilities | Industry News
      CatSci Expands Capabilities with Lab Expansion

      CatSci Expands Capabilities with Lab Expansion

      Continuing strategic growth.
      CatSci 12.11.19

    • Breaking News | Industry News | Promotions & Moves | Solid Dosage/Creams/Ointments
      Bora Names President of North American Ops

      Bora Names President of North American Ops

      Sam Ricchezza to lead the Taiwan-based CDMO’s North American push.
      11.20.19


    • Formulation Development | Solid Dosage/Semi-solids
      Adare Pharmaceuticals

      Adare Pharmaceuticals' Cheryl Wood

      Adare's director of business development discusses solid dose formulations, amongst other capabilities.
      Contract Pharma Staff

    • Bio News | Breaking News | Industry News
      Mylan, Pfizer Unveil Combined Company Name

      Mylan, Pfizer Unveil Combined Company Name

      Viatris will be the name of the Mylan-Upjohn combination company.
      11.13.19

    • Tedor Pharma’s Terry Novak

      Tedor Pharma’s Terry Novak

      Tedor Pharma's chief operating officer highlights company capabilities.
      Contract Pharma Staff


    • cGMP Manufacture | Drug Development
      Contract Pharma’s 20th Anniversary Series: CDMO Insight

      Contract Pharma’s 20th Anniversary Series: CDMO Insight

      JoyL Silva of Pfizer CentreOne discusses global market and regulatory changes driving drug development strategies and the evolution of CDMO services and ops.
      Kristin Brooks, Contract Pharma 11.01.19

    • A Witness to the Growth of Outsourcing

      A Witness to the Growth of Outsourcing

      Observations from the 2019 Contract Pharma Conference.
      Emil W. Ciurczak, DoraMaxx Consulting 10.15.19

    • cGMP Manufacture
      Deriving Value from Integrated cGMP and Pre-GMP Manufacturing Operations

      Deriving Value from Integrated cGMP and Pre-GMP Manufacturing Operations

      The benefits of leveraging a mix of GMP and pre-GMP facilities.
      Didier Combis, Commercial Director, Seqens CDMO 10.15.19


    • Contract Pharma’s 20th Anniversary Retrospective

      Contract Pharma’s 20th Anniversary Retrospective

      A look back a the pharma/biopharma industry and the future of outsourcing.
      Kristin Brooks, Managing Editor, Contract Pharma 10.15.19

    • Breaking News | Drug Development | Industry News
      Akcea, Pfizer Enter Licensing Agreement for Antisense Therapy

      Akcea, Pfizer Enter Licensing Agreement for Antisense Therapy

      AKCEA-ANGPTL3-LRx is in Phase II development for the treatment of certain cardiovascular and metabolic diseases
      10.07.19

    • Aseptic Processing | Breaking News | Industry News
      Enesi Gets Innovate UK Funding for Aseptic Mfg.

      Enesi Gets Innovate UK Funding for Aseptic Mfg.

      Enables scalable aseptic manufacturing of ImplaVax-enabled solid dose viral vector vaccines
      09.25.19


    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
      Continued and Consistent Investment in Manufacturing Facilities

      Continued and Consistent Investment in Manufacturing Facilities

      As companies move their cell and gene therapies through the development process, supporting larger Phase III trials and commercial launches will be a challenge
      Ryan Carpentier, Executive Director of Business Development, Cryoport 09.23.19

    • Breaking News | Collaborations & Alliances | Industry News | Information Technology | Supply Chain
      Almac Participates in Global Clinical Supply BlockChain Working Group

      Almac Participates in Global Clinical Supply BlockChain Working Group

      Project spearheaded by Biogen and Pfizer explores how technology can address the growing demands of clinical trials
      09.18.19